Complete remission of diffuse hepatocellular carcinoma in a young adult after GSP-TACE: a case report
Open Access
- 25 September 2014
- journal article
- case report
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 12 (1) , 300
Abstract
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver. It mostly occurs in older age groups (usually those 50 to 60 years old), and rarely in young adults. The survival rate of these young HCC patients is usually very low. The authors report a case of a 22-year old man with diffuse-type HCC who successfully achieved complete remission for 46 months after second transcatheter arterial chemoembolization using gelatin sponge particles (Eric Kang Pharmaceutical Technology Co., Ltd. Hangzhou, China) combined with pirarubicin.Keywords
This publication has 22 references indexed in Scilit:
- Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantationBMC Cancer, 2012
- Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and OutcomesAnnals of Surgical Oncology, 2012
- Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the ForestJournal of Gastrointestinal Surgery, 2011
- Overall Survival After Transarterial Lipiodol Infusion Chemotherapy With or Without Embolization for Unresectable Hepatocellular Carcinoma: Propensity Score AnalysisAmerican Journal of Roentgenology, 2010
- Right Atrial Metastasis Mimicking Myxoma in Advanced Hepatocellular CarcinomaEchocardiography, 2010
- Hepatocellular Carcinoma in Young Adults: The Clinical Characteristics, Prognosis, and Findings of a Patient Survival AnalysisDigestive Diseases and Sciences, 2007
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinomaJournal of the American College of Surgeons, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999